Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.62 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.58 |
| ▸ | LOXL2 | Q9Y4K0 | 5/20 | 0.55 |
| ▸ | ABAT | P80404 | 1/20 | 0.52 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | PLAU | P00749 | 1/20 | 0.46 |
| ▸ | NOS3 | P29474 | 1/20 | 0.46 |
| ▸ | NOS1 | P29475 | 1/20 | 0.46 |
| ▸ | NOS2 | P35228 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | LPL | P06858 | 1/20 | 0.46 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13814906 | 0.92 | HRH3 (0.74) | TAAR1HRH3LOXL2ABATPSIP1 | |
| SCHEMBL26030924 | 0.92 | TAAR1 (0.54) | TAAR1HRH3LOXL2ABATPSIP1 | |
| SCHEMBL22536884 | 0.92 | TAAR1 (0.68) | TAAR1HRH3LOXL2ABATPSIP1 | |
| Ethylbenzene SCHEMBL27229 | 0.86 | LOXL2 (0.74) | TAAR1HRH3LOXL2TP53SMN1; SMN2 | |
| SCHEMBL27812178 | 0.85 | LOXL2 (0.52) | TAAR1HRH3LOXL2ABATPSIP1 | |
| SCHEMBL920620 | 0.85 | ST14 (0.68) | TAAR1HRH3LOXL2PSIP1SMN1; SMN2 | |
| Ethylbenzene SCHEMBL8625152 | 0.84 | LOXL2 (0.70) | TAAR1HRH3LOXL2TP53SMN1; SMN2 | |
| Ethylbenzene SCHEMBL9229968 | 0.84 | LOXL2 (0.70) | TAAR1HRH3LOXL2TP53SMN1; SMN2 | |
| Methylamine SCHEMBL27540106 | 0.83 | TAAR1 (0.63) | TAAR1TP53CA2SMN1; SMN2PLAU | |
| SCHEMBL15828 | 0.83 | HRH3 (0.79) | TAAR1HRH3LOXL2ABATPSIP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 964 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118325204-A | Low-temperature-rise rubber and carbon black composition and preparation method thereof | 华南理工大学 | 2024-07-12 | — | — | CN | claimed |
| CN-112543781-B | Polybenzimidazole oligomers having reactive end groups | PBI性能产品公司 | 2024-02-20 | — | — | CN | claimed |
| CN-116430026-A | Nucleotide analysis method based on pairing derivatization technology | 中国药科大学 | 2023-07-14 | — | — | CN | claimed |
| CN-114381247-B | Synthesis of branched epoxy resin pressure-bearing plugging material | 西南石油大学 | 2023-04-25 | — | — | CN | claimed |
| CN-114381247-A | Synthesis of branched epoxy resin pressure-bearing plugging material | 西南石油大学 | 2022-04-22 | — | — | CN | claimed |
| CN-105505128-B | Near-infrared light response self-repairing coating and preparation method thereof | 南京工业大学 | 2018-05-08 | — | — | CN | claimed |
| CN-101611005-A | Be used as the acetophenones of the replacement of PDE4 inhibitor | LEO PHARMA AS (DK) | 2009-12-23 | — | — | CN | claimed |
| US-20070066682-A1 | Arylalkylamine vanadium (V) salts for the treatment and/or prevention of Diabetes mellitus | GENMEDICA THERAPEUTICS SL (ES) | 2007-03-22 | — | — | US | claimed |
| WO-2026105418-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR WAFER | 三菱瓦斯化学株式会社 | 2026-05-21 | — | — | WO | disclosed |
| CN-122029256-A | Method for refining pyrolysis oil | 株式会社LG化学 | 2026-05-12 | — | — | CN | disclosed |
| EP-4737538-A1 | METHOD FOR REFINING PYROLYSIS OIL | LG Chem, Ltd. (KR) | 2026-05-06 | — | — | EP | disclosed |
| US-12584015-B2 | Polyimide resin composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-03-24 | — | — | US | disclosed |
| EP-4696736-A1 | POLYIMIDE RESIN PRECURSOR, POLYIMIDE RESIN, AND POLYIMIDE FILM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-02-18 | — | — | EP | disclosed |
| US-20260022208-A1 | POLYIMIDE RESIN, POLYIMIDE VARNISH, POLYIMIDE FILM, AND TEMPORARY FIXING MATERIAL COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-01-22 | — | — | US | disclosed |
| US-4792628-A | ANTIOXIDANTS, ANTIINFLAMMATORY AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1988-12-20 | — | — | US | disclosed |
| EP-0195515-A1 | Preparation of urethanes by oxidative carbonylation of amines using copper carboxylates as oxidants | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-09-24 | — | — | EP | disclosed |
| US-4203898-A | ANTICARCINOGENIC | ELI LILLY AND COMPANY (US) | 1980-05-20 | — | — | US | disclosed |
| US-4058477-A | P-((P-ALKYLBENZYLIDEN)AMINO)-BENZONITRILE | HOFFMANN-LA ROCHE INC. (US) | 1977-11-15 | — | — | US | disclosed |
| US-4027037-A | ARTHROPOD METAMORPHOSIS INHIBITORS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-05-31 | — | — | US | disclosed |
| US-3963313-A | Liquid crystal Schiffs bases | HOFFMANN-LA ROCHE INC. (US) | 1976-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066682-A1 | Arylalkylamine vanadium (V) salts for the treatment and/or prevention of Diabetes mellitus | GPR119, ABCC1, INSR | TAAR1 344/4885HRH3 1172/4885LOXL2 3562/4885 |
| US-20260022208-A1 | POLYIMIDE RESIN, POLYIMIDE VARNISH, POLYIMIDE FILM, AND TEMPORARY FIXING MATERIAL COMPOSITION | SETDB1, FEM1B, F9 | TAAR1 1481/4885HRH3 798/4885LOXL2 2177/4885 |
| US-12584015-B2 | Polyimide resin composition | PSMA1, SEM1, RIF1 | TAAR1 464/4885HRH3 438/4885LOXL2 1379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.